AVIR - CIK 0001593899
Atea Pharmaceuticals, Inc. has filed 301 documents with the SEC between 2013 and 2026. The most frequent type is insider trade (98 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-03-06 | 2025-03-06 |
| Annual report | 10-K | 2025-03-06 | 2024-12-31 |
| SCHEDULE 13D | - | 2025-03-04 | - |
| Major company event | 8-K | 2025-02-24 | 2025-02-20 |
| Insider trade | 4 | 2025-02-24 | 2025-02-20 |
| New insider ownership | 3 | 2025-02-24 | 2025-02-20 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Insider trade (amended) | 4/A | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Major company event | 8-K | 2025-01-14 | 2025-01-13 |
| SCHEDULE 13D | - | 2024-12-16 | - |
| Insider trade | 4 | 2024-12-12 | 2024-12-10 |
| Insider sale notice | 144 | 2024-12-10 | - |
| EFFECT | - | 2024-11-19 | - |
| Company correspondence | CORRESP | 2024-11-15 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| SEC correspondence | UPLOAD | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Securities registration | S-3 | 2024-11-07 | - |
| Major company event | 8-K | 2024-11-07 | 2024-11-07 |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Insider sale notice | 144 | 2024-09-19 | - |
| Insider trade | 4 | 2024-09-19 | 2024-09-17 |
| Insider sale notice | 144 | 2024-09-18 | - |
| Insider sale notice | 144 | 2024-09-17 | - |
| Major company event | 8-K | 2024-08-07 | 2024-08-07 |
| Quarterly report | 10-Q | 2024-08-07 | 2024-06-30 |
| Major company event | 8-K | 2024-06-21 | 2024-06-21 |
| Insider trade | 4 | 2024-06-21 | 2024-06-21 |
| Insider trade | 4 | 2024-06-21 | 2024-06-21 |
| Insider trade | 4 | 2024-06-21 | 2024-06-21 |
| Insider trade | 4 | 2024-06-21 | 2024-06-21 |
| Insider trade | 4 | 2024-06-21 | 2024-06-20 |
| Insider trade | 4 | 2024-06-21 | 2024-06-21 |
| Insider sale notice | 144 | 2024-06-20 | - |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-18 | 2024-06-16 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Insider sale notice | 144 | 2024-06-05 | - |
| Proxy materials | DEFA14A | 2024-06-04 | - |